ResApp shares spike on EU green light

23/08/2019 - 15:18

Bookmark

Save articles for future reference.

Shares in digital health company ResApp Health have closed up 33 per cent today to 20 cents, after it received European regulatory approval for its first commercial product – the ResAppDx-EU.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options